Search for: "Central Research, Inc." Results 41 - 60 of 1,149
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Nov 2014, 7:32 am by Jason Rantanen
A central focus of the Professor Lucas Osborn‘s research is infringement by offers to sell. [read post]
7 Jun 2010, 9:36 am by Stephen Albainy-Jenei
The Jackson Laboratory, a biomedical research institution and repository for laboratory mice, won a summary judgment of no patent infringement against The Central Institute for Experimental Animals (CIEA). [read post]
23 Sep 2014, 5:30 am by Kori Shafer-Stack
The funds will support CARERC as a cohesive, fully equipped and recognized resource for occupational safety and health research and training in central Appalachia. [read post]
24 Jul 2012, 8:57 am by David Jensen
” Capela said this “contradicts previous acceptance of this strategy by CIRM and constitutes a central reason for our appeal to the (CIRM board). [read post]
10 Feb 2017, 9:46 pm by Mark Summerfield
  The Research Affiliates and RPL Central matters both ultimately ended up on appeal before a Full Bench of the Federal Court of Australia, which confirmed that the claims in each case were not patent-eligible, albeit for reasons somewhat different from the Patent Office’s ‘centrality of purpose’ test.While published reasons are the most visible and detailed outcomes of Patent Office decision-making, they typically have their genesis some months… [read post]
21 Aug 2023, 2:32 am by centerforartlaw
The lawsuit was filed in the Central District of California.[3] Yuga contends that Ryder Ripps engaged in deceptive practices aimed at duping consumers into acquiring a copycat NFT collection resembling the original Bored Ape Yacht Club images. [read post]
15 Jul 2011, 2:10 pm
NY-based Acorda Therapeutics, Inc. has licensed worldwide development and commercialization rights to a proprietary magnesium formula (referred to as AC105) from Medtronic, Inc. [read post]
13 Aug 2017, 12:54 am by Mark Summerfield
  This suggests to me that the Patent Office is continuing to grapple with the principles of patent-eligibility set out in Research Affiliates, RPL Central, and D’Arcy v Myriad Genetics Inc [2015] HCA 35, and that applicants therefore still cannot expect predictable or consistent outcomes as examiners endeavour to apply these principles on a case-by-case basis. [read post]
24 Sep 2017, 4:00 am by Administrator
The chambers judge found that the Board erred by falling into the “trap” revealed in the Court of Appeal’s decision in Southam Inc. v. [read post]
28 Apr 2013, 4:00 am by Administrator
COMMENT BY COUNSEL FOR THE APPELLANT RESOLUTE FP CANADA INC., Christopher J. [read post]
16 Jul 2014, 12:13 pm by David Jensen
According to the article, the complaint said that StemCells, Inc., of Newark, Ca., says its stem cells are safe for human transplantation. [read post]
29 May 2020, 6:55 am by James Goodman
StubHub, Inc., et al., 2:17-cv-04062-SVW-SS, the United States District Court for the Central District of California dismissed almost all the remaining claims against StubHub and the other defendants. [read post]
2 Jun 2023, 7:54 am by Zak Gowen
Eighteen central banks said they were in the research phase of CBDC development. [read post]